In contrast to naltrexone, which mainly binds to the mu opioid receptor, nalmefene acts as a more potent antagonist at the mu, delta, and kappa opioid receptors.32 Nalmefene’s activity at the kappa opioid receptor is of interest because activation of this receptor is associated with increases in anxiety and dysphoria. Here, OPRK1 is linked to dysphoria.